The Simplified Thrombo-Inflammatory Score as a Novel Predictor of All-Cause Mortality in Patients with Heart Failure: A Retrospective Cohort Study

References

• Shah SJ, Katz DH, Selvaraj S, et al. Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation. 2015;131(3):269–279. doi:10.1161/CIRCULATIONAHA.114.010637
   PubMed Web of Science ®Google Scholar
• Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2022 update: a report from the American heart association. Circulation. 2022;145(8):e153–e639. doi:10.1161/CIR.0000000000001052
   PubMed Web of Science ®Google Scholar
• McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi:10.1093/eurheartj/ehab368
   PubMed Web of Science ®Google Scholar
• Singh S, Pandey A, Neeland IJ. Diagnostic and prognostic considerations for use of natriuretic peptides in obese patients with heart failure. Prog Cardiovasc Dis. 2020;63(5):649–655. doi:10.1016/j.pcad.2020.09.006
   PubMed Web of Science ®Google Scholar
• Shirakabe A, Okazaki H, Matsushita M, et al. Hyperuricemia complicated with acute kidney injury is associated with adverse outcomes in patients with severely decompensated acute heart failure. Int J Cardiol Heart Vasc. 2019;23:100345. doi:10.1016/j.ijcha.2019.03.005
   PubMed Web of Science ®Google Scholar
• Engström G, Melander O, Hedblad B. Leukocyte count and incidence of hospitalizations due to heart failure. Circ Heart Fail. 2009;2(3):217–222. doi:10.1161/CIRCHEARTFAILURE.108.827071
   PubMed Web of Science ®Google Scholar
• Horwich TB, Hamilton MA, Maclellan WR, et al. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail. 2002;8(4):216–224. doi:10.1054/jcaf.2002.0804216
   PubMed Web of Science ®Google Scholar
• Yamaguchi S, Abe M, Arakaki T, et al. Incremental prognostic value of platelet count in patients with acute heart failure - a retrospective observational study. Circ J. 2019;83(3):576–583. doi:10.1253/circj.CJ-18-0961
   PubMed Web of Science ®Google Scholar
• Menghoum N, Beauloye C, Lejeune S, et al. Mean platelet volume: a prognostic marker in heart failure with preserved ejection fraction. Platelets. 2023;34(1):2188965. doi:10.1080/09537104.2023.2188965
   PubMed Web of Science ®Google Scholar
• Çınar T, Şaylık F, Akbulut T, et al. Evaluation of intermountain risk score for short- and long-term mortality in ST elevation myocardial infarction patients. Angiology. 2023;74(4):357–364. doi:10.1177/00033197221105753
   PubMed Web of Science ®Google Scholar
• Mert Ilker H, Faysal S, Ahmet Çağdaş Y, et al. Prognostic value of intermountain risk score for short- and long-term mortality in patients with cardiogenic shock. Coron Artery Dis. 2023;34(2):154–159. doi:10.1097/MCA.0000000000001219
   PubMed Web of Science ®Google Scholar
• Şaylık F, Çınar T, Selçuk M, et al. Evaluation of Naples score for long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2023;2:00033197231170982.
   Google Scholar
• Zheng YY, Wu TT, Gao Y, et al. A novel ABC score predicts mortality in non-ST-segment elevation acute coronary syndrome patients who underwent percutaneous coronary intervention. Thromb Haemost. 2021;121(03):297–308. doi:10.1055/s-0040-1718411
   PubMed Web of Science ®Google Scholar
• Glezeva N, Gilmer JF, Watson CJ, et al. A central role for monocyte-platelet interactions in heart failure. J Cardiovasc Pharmacol Ther. 2016;21(3):245–261. doi:10.1177/1074248415609436
   PubMed Web of Science ®Google Scholar
• Abu-Fanne R, Stepanova V, Litvinov RI, et al. Neutrophil α-defensins promote thrombosis in vivo by altering fibrin formation, structure, and stability. Blood. 2019;133(5):481–493. doi:10.1182/blood-2018-07-861237
   PubMed Web of Science ®Google Scholar
• Li DZ, Li XM, Sun HP, et al. A novel simplified thrombo-inflammatory prognostic score for predicting in-hospital complications and long-term mortality in patients with type A acute aortic dissection: a prospective cohort study. Eur Heart J Suppl. 2015;17:C26–C33.
   Web of Science ®Google Scholar
• Hudzik B, Szkodziński J, Wasilewski J, et al. A novel simplified thrombo-inflammatory score portends poor outcome in diabetic patients following myocardial infarction. Biomarker Med. 2016;10(11):1129–1139. doi:10.2217/bmm-2016-0145
   PubMed Web of Science ®Google Scholar
• Poelzl G, Fetz B, Altenberger J, et al. Heart failure disease management programs in Austria 2019: a systematic survey of the heart failure working group and the working group for cardiological assistance and care personnel of the Austrian society of cardiology. Wien Klin Wochenschr. 2020;132(11–12):310–321. doi:10.1007/s00508-020-01615-y
   PubMed Web of Science ®Google Scholar
• Hayıroğlu Mİ, Çınar T, Çinier G. Prognostic value of serum albumin for long-term mortality in patients with dual-chamber permanent pacemakers. Biomarker Med. 2022;16(5):341–348. doi:10.2217/bmm-2021-0991
   PubMed Web of Science ®Google Scholar
• Çinier G, Hayıroğlu Mİ, Kolak Z, et al. The value of C-reactive protein-to-albumin ratio in predicting long-term mortality among HFrEF patients with implantable cardiac defibrillators. Eur J Clin Invest. 2021;51(8):e13550. doi:10.1111/eci.13550
   PubMed Web of Science ®Google Scholar
• Gustafsson F, Torp-Pedersen C, Seibaek M, et al. Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure. Eur Heart J. 2004;25(19):1711–1717. doi:10.1016/j.ehj.2004.07.007
   PubMed Web of Science ®Google Scholar
• Shiomura R, Kobayashi N, Shirakabe A, et al. Systolic blood pressure and cardiac mortality related to serum total bilirubin levels at admission in patients with acute heart failure. Heart Ves. 2021;36(1):69–75. doi:10.1007/s00380-020-01666-1
   PubMed Web of Science ®Google Scholar
• Sirtori CR, Ruscica M, Calabresi L, et al. HDL therapy today: from atherosclerosis, to stent compatibility to heart failure. Ann Med. 2019;51(7–8):345–359. doi:10.1080/07853890.2019.1694695
   PubMed Web of Science ®Google Scholar
• Dutka M, Bobiński R, Ulman-Włodarz I, et al. Various aspects of inflammation in heart failure. Heart Fail Rev. 2020;25(3):537–548. doi:10.1007/s10741-019-09875-1
   PubMed Web of Science ®Google Scholar
• Chaikijurajai T, Tang WHW. Reappraisal of Inflammatory Biomarkers in Heart Failure. Curr Heart Fail Rep. 2020;17(1):9–19. doi:10.1007/s11897-019-00450-1
   PubMed Web of Science ®Google Scholar
• Dick SA, Epelman S. Chronic heart failure and inflammation: what do we really know? Circul Res. 2016;119(1):159–176. doi:10.1161/CIRCRESAHA.116.308030
   PubMed Web of Science ®Google Scholar
• DuBrock HM, AbouEzzeddine OF, Redfield MM, Fukumoto Y. High-sensitivity C-reactive protein in heart failure with preserved ejection fraction. PLoS One. 2018;13(8):e0201836. doi:10.1371/journal.pone.0201836
   PubMed Web of Science ®Google Scholar
• Koller L, Kleber M, Goliasch G, et al. C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction. Eur J Heart Fail. 2014;16(7):758–766. doi:10.1002/ejhf.104
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhou S. Leukocyte count and the risk of adverse outcomes in patients with HFpEF. BMC Cardiovasc Disord. 2021;21(1):333. doi:10.1186/s12872-021-02142-y
   PubMed Web of Science ®Google Scholar
• Vaduganathan M, Greene SJ, Butler J, et al. The immunological axis in heart failure: importance of the leukocyte differential. Heart Fail Rev. 2013;18(6):835–845. doi:10.1007/s10741-012-9352-9
   PubMed Web of Science ®Google Scholar
• Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science. 2013;339(6116):161–166. doi:10.1126/science.1230719
   PubMed Web of Science ®Google Scholar
• Schafer A, Eigenthaler M, Bauersachs J. Platelet activation in heart failure. Clin Lab. 2004;50(9–10):559–566.
   PubMedGoogle Scholar
• Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res. 2013;112(11):1506–1519. doi:10.1161/CIRCRESAHA.113.300512
   PubMed Web of Science ®Google Scholar
• Mojadidi MK, Galeas JN, Goodman-Meza D, et al. Thrombocytopaenia as a prognostic indicator in heart failure with reduced ejection fraction. Heart Lung Circ. 2016;25(6):568–575. doi:10.1016/j.hlc.2015.11.010
   PubMed Web of Science ®Google Scholar
• Kaya H, Kutay Yıldırımlı M, Kurt R, et al. Mean platelet volume as a predictor of heart failure-related hospitalizations in stable heart failure outpatients with sinus rhythm. Acta Cardiol Sin. 2017;33(3):292–300. doi:10.6515/acs20160930a
   PubMed Web of Science ®Google Scholar
• Nagareddy P, Smyth SS. Inflammation and thrombosis in cardiovascular disease. Curr Opin Hematol. 2013;20(5):457–463. doi:10.1097/MOH.0b013e328364219d
   PubMed Web of Science ®Google Scholar
• Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. 2021p;18(9):666–682. doi:10.1038/s41569-021-00552-1
   PubMed Web of Science ®Google Scholar
• Delcea C, Buzea CA, Vîjan AE, et al. The platelet to lymphocyte ratio in heart failure: a comprehensive review. Rom J Intern Med. 2023;61(2):84–97. doi:10.2478/rjim-2023-0006
   PubMed Web of Science ®Google Scholar
• Peterson PN, Rumsfeld JS, Liang L, et al. A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. Circ Cardiovasc Qual Outcomes. 2010;3(1):25–32.
   PubMed Web of Science ®Google Scholar
• Sonaglioni A, Lonati C, Rigamonti E, et al. CHA2DS2-VASc score stratifies mortality risk in heart failure patients aged 75 years and older with and without atrial fibrillation. Aging Clin Exp Res. 2022;34(7):1707–1720. doi:10.1007/s40520-022-02107-x
   PubMed Web of Science ®Google Scholar